Pulmonx Corp Stock Revenue
| LUNG Stock | USD 6.61 0.18 2.65% |
Pulmonx Corp fundamentals help investors to digest information that contributes to Pulmonx Corp's financial success or failures. It also enables traders to predict the movement of Pulmonx Stock. The fundamental analysis module provides a way to measure Pulmonx Corp's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pulmonx Corp stock.
| Last Reported | Projected for Next Year | ||
| Total Revenue | 68.7 M | 72.1 M |
Pulmonx | Revenue |
Pulmonx Corp Company Revenue Analysis
Pulmonx Corp's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Pulmonx Corp Revenue | 68.67 M |
Most of Pulmonx Corp's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pulmonx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Historical and Projected quarterly revenue of Pulmonx
Projected quarterly revenue analysis of Pulmonx Corp provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of Pulmonx Corp match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in Pulmonx Corp's stock price.
Pulmonx Revenue Driver Correlations
Understanding the fundamental principles of building solid financial models for Pulmonx Corp is extremely important. It helps to project a fair market value of Pulmonx Stock properly, considering its historical fundamentals such as Revenue. Since Pulmonx Corp's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pulmonx Corp's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pulmonx Corp's interrelated accounts and indicators.
| -0.4 | -0.43 | 0.27 | -0.2 | 0.63 | ||
| -0.4 | 0.99 | 0.27 | 0.66 | -0.64 | ||
| -0.43 | 0.99 | 0.28 | 0.6 | -0.62 | ||
| 0.27 | 0.27 | 0.28 | 0.25 | -0.38 | ||
| -0.2 | 0.66 | 0.6 | 0.25 | -0.55 | ||
| 0.63 | -0.64 | -0.62 | -0.38 | -0.55 |
Click cells to compare fundamentals
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Pulmonx Current Deferred Revenue
Current Deferred Revenue |
|
Based on the latest financial disclosure, Pulmonx Corp reported 68.67 M of revenue. This is 99.1% lower than that of the Health Care Equipment & Supplies sector and 97.31% lower than that of the Health Care industry. The revenue for all United States stocks is 99.27% higher than that of the company.
Pulmonx Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulmonx Corp's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics of similar companies.Pulmonx Corp is currently under evaluation in revenue category among its peers.
Pulmonx Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Pulmonx Corp from analyzing Pulmonx Corp's financial statements. These drivers represent accounts that assess Pulmonx Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Pulmonx Corp's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 1.4B | 2.5B | 1.2B | 312.7M | 484.2M | 460.0M | |
| Enterprise Value | 1.4B | 2.3B | 1.0B | 235.4M | 442.1M | 420.0M |
Pulmonx Corp ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pulmonx Corp's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pulmonx Corp's managers, analysts, and investors.Environmental | Governance | Social |
Pulmonx Corp Institutional Holders
Institutional Holdings refers to the ownership stake in Pulmonx Corp that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pulmonx Corp's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pulmonx Corp's value.| Shares | Franklin Resources Inc | 2024-09-30 | 700.4 K | Rock Springs Capital Management Lp | 2024-06-30 | 652.4 K | Pura Vida Investments, Llc | 2024-09-30 | 509.8 K | Altium Capital Management, Lp | 2024-09-30 | 500 K | Millennium Management Llc | 2024-06-30 | 448.6 K | Partner Fund Management Lp | 2024-09-30 | 368.9 K | Northern Trust Corp | 2024-09-30 | 362.2 K | D. E. Shaw & Co Lp | 2024-09-30 | 360.8 K | Dimensional Fund Advisors, Inc. | 2024-09-30 | 347.5 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 6.9 M | Fmr Inc | 2024-09-30 | 5.9 M |
Pulmonx Fundamentals
| Return On Equity | -0.52 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.72) % | ||||
| Operating Margin | (0.69) % | ||||
| Current Valuation | 216.15 M | ||||
| Shares Outstanding | 39.49 M | ||||
| Shares Owned By Insiders | 5.16 % | ||||
| Shares Owned By Institutions | 94.90 % | ||||
| Number Of Shares Shorted | 986.14 K | ||||
| Price To Book | 2.85 X | ||||
| Price To Sales | 3.38 X | ||||
| Revenue | 68.67 M | ||||
| Gross Profit | 39.87 M | ||||
| EBITDA | (55.09 M) | ||||
| Net Income | (60.84 M) | ||||
| Cash And Equivalents | 162.09 M | ||||
| Cash Per Share | 4.35 X | ||||
| Total Debt | 41.42 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.43 X | ||||
| Book Value Per Share | 2.38 X | ||||
| Cash Flow From Operations | (37.61 M) | ||||
| Short Ratio | 4.92 X | ||||
| Earnings Per Share | (1.47) X | ||||
| Price To Earnings To Growth | (0.42) X | ||||
| Target Price | 13.5 | ||||
| Number Of Employees | 279 | ||||
| Beta | 0.68 | ||||
| Market Capitalization | 268.12 M | ||||
| Total Asset | 177.78 M | ||||
| Retained Earnings | (411.16 M) | ||||
| Working Capital | 127.27 M | ||||
| Net Asset | 177.78 M |
About Pulmonx Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:Check out Pulmonx Corp Piotroski F Score and Pulmonx Corp Altman Z Score analysis. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.47) | Revenue Per Share 2.043 | Quarterly Revenue Growth 0.154 | Return On Assets (0.20) | Return On Equity (0.52) |
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.